Evidence map›Paper›PMID 42086744›Full record

ArticleScientific reports2026

Brain reward function in people with moderate-to-severe cannabis use disorder who tried to cut down or quit: an fMRI study.

Emillie Beyer, Martine Skumlien, Govinda Poudel, Arush Honnedevasthana Arun, Eugene McTavish, Hannah Thomson, Hannah Sehl, Rebecca Segrave, Adam Clemente, Izelle Labuschagne and 5 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Emillie BeyerNeuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Level 5 Daniel Mannix Building, 115 Victoria Parade, Fitzroy, VIC, Australia.
Martine SkumlienDepartment of Social, Genetic & Developmental Psychiatry Centre (SGDP), Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Govinda PoudelMary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, VIC, Australia.
Arush Honnedevasthana ArunNeuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Level 5 Daniel Mannix Building, 115 Victoria Parade, Fitzroy, VIC, Australia.
Eugene McTavishNeuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Level 5 Daniel Mannix Building, 115 Victoria Parade, Fitzroy, VIC, Australia.
Hannah ThomsonNeuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Level 5 Daniel Mannix Building, 115 Victoria Parade, Fitzroy, VIC, Australia.
Hannah SehlNeuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Level 5 Daniel Mannix Building, 115 Victoria Parade, Fitzroy, VIC, Australia.
Rebecca SegraveUrner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, VIC, Australia.
Adam ClementeSchool of Behavioural & Health Sciences, Australian Catholic University, Fitzroy, VIC, Australia.
Izelle LabuschagneSchool of Behavioural & Health Sciences, Australian Catholic University, Fitzroy, VIC, Australia.
Peter RendellSchool of Behavioural & Health Sciences, Australian Catholic University, Fitzroy, VIC, Australia.
Gill TerrettSchool of Behavioural & Health Sciences, Australian Catholic University, Fitzroy, VIC, Australia.
Victoria ManningTurning Point, Eastern Health, Monash University, Melbourne, VIC, Australia.
Chao SuoNeuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Level 5 Daniel Mannix Building, 115 Victoria Parade, Fitzroy, VIC, Australia.
Valentina LorenzettiNeuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Level 5 Daniel Mannix Building, 115 Victoria Parade, Fitzroy, VIC, Australia. valentina.lorenzetti@gmail.com.

Funding

National Health and Medical Research Council 2016833
6 · The paper itself

Abstract

Cannabis Use Disorder (CUD) affects ~ 50 million individuals globally. CUD has been associated with adverse psychosocial outcomes, including affective flattening, apathy, and anhedonia, which prominent neuroscientific theories ascribe (in part) to altered integrity in brain reward pathways. Yet, emerging evidence from functional neuroimaging (fMRI) is mixed. We examined the activity in key regions-of-interest (ROIs) of the reward neurocircuitry in moderate-to-severe CUD vs. controls, and associations with cannabis use patterns in addition to Apathy Evaluation Scale scores. Brain reward function was examined in 57 people with moderate-to-severe CUD and 35 age and sex-matched controls using the Monetary Incentive Delay fMRI task. We compared brain function between groups, adjusting for age and sex, using exploratory whole-brain and hypothesis-driven ROI analyses in the ventral striatum, dorsal caudate, putamen, insula, cingulate, and orbitofrontal cortices. ROI analyses showed greater activity in the CUD vs. control group in bilateral insula and right putamen when receiving monetary wins vs. receiving neutral wins (i.e., outcomes with no monetary gain). The ROI analysis also showed greater activity in the CUD vs. controls in the right putamen when receiving monetary wins vs. receiving missed monetary wins. There were no other significant effects for the other ROIs, the whole-brain analyses, or brain-behaviour correlations. Overall, people with CUD showed altered activity in key brain reward regions during the receipt phase of rewards, compared to controls.

Indexed as

BrainMagnetic Resonance ImagingMarijuana AbuseRewardAdultBrain MappingCase-Control StudiesFemaleHumansMaleYoung Adult

Identifiers

PMID42086744
PMCPMC13333791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.